Smith & Nephew plc (LON:SN – Get Free Report) announced a dividend on Tuesday, February 25th, DividendData.Co.Uk reports. Investors of record on Thursday, March 27th will be paid a dividend of $0.23 per share on Wednesday, May 28th. This represents a yield of 1.61%. The ex-dividend date of this dividend is Thursday, March 27th. This is a 60.4% increase from Smith & Nephew’s previous dividend of $0.14. The official announcement can be accessed at this link.
Smith & Nephew Stock Performance
Shares of Smith & Nephew stock opened at GBX 1,080 ($13.96) on Tuesday. The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84. The stock’s 50-day simple moving average is GBX 1,063.18 and its two-hundred day simple moving average is GBX 1,053.59. The stock has a market cap of £11.84 billion, a P/E ratio of 38.88, a P/E/G ratio of 0.46 and a beta of 0.62.
Wall Street Analysts Forecast Growth
Separately, JPMorgan Chase & Co. reiterated an “overweight” rating and issued a GBX 1,180 ($15.25) target price on shares of Smith & Nephew in a research note on Tuesday, January 14th.
Smith & Nephew Company Profile
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Further Reading
- Five stocks we like better than Smith & Nephew
- 3 Healthcare Dividend Stocks to Buy
- Top 3 Insider Stock Buys in March—Are They Still Good in April?
- Consumer Staples Stocks, Explained
- Pharma Frenzy: Volatility Ignites Biotech Sector
- Golden Cross Stocks: Pattern, Examples and Charts
- Warren Buffett Thinks This Country Could Be the Next Big Bet
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.